Corline Biomedical AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 1991-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.corline.com
Clinical Trials
5
Active:2
Completed:1
Trial Phases
3 Phases
Phase 1:3
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Not Applicable
1 (20.0%)Phase 2
1 (20.0%)Renaparin® in Kidney Transplantation
- First Posted Date
- 2018-12-12
- Last Posted Date
- 2020-07-01
- Lead Sponsor
- Corline Biomedical AB
- Target Recruit Count
- 16
- Registration Number
- NCT03773211
- Locations
- 🇸🇪
Transplantationscentrum, Sahlgrenska University Hospital, Gothenburg, Sweden
🇸🇪Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Stockholm, Sweden
🇸🇪Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala University Hospital, Uppsala, Sweden
Heparinized Islets in Clinical Islet Transplantation
Not Applicable
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2018-12-10
- Lead Sponsor
- Corline Biomedical AB
- Target Recruit Count
- 10
- Registration Number
- NCT00678990
- Locations
- 🇸🇪
Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden
🇸🇪Department of Transplantation and Liver Surgery, Uppsala University Hospital, Uppsala, Sweden
News
No news found